Antibody responses to 2 doses of mRNA COVID-19 vaccine in pediatric patients with kidney diseases

被引：9
|
作者：
Ma, Alison Lap-Tak [1 ]
Leung, Daniel [2 ]
Chan, Eugene Yu-Hin [1 ]
Chim, Stella [3 ]
Cheng, Samuel
Ho, Fanny Tsz-Wai [1 ]
Lai, Wai-Ming [1 ]
Tong, Pak-Chiu [1 ]
Lee, Matthew Hon-Lam [3 ]
Wong, Wilfred Hing-Sang [2 ]
Chan, Sau Man [2 ]
Duque, Jaime Rosa [2 ]
Peiris, Joseph Sriyal Malik [4 ]
Lau, Yu Lung [2 ]
机构：
[1] Hong Kong Childrens Hosp, Dept Paediat & Adolescent Med, Paediat Nephrol Ctr, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[4] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China
来源：
KIDNEY INTERNATIONAL | 2022年 / 101卷 / 05期
关键词：
antibody; BNT162b2; COVID-19; mRNA; nephrology; pediatric; vaccine;
D O I：
10.1016/j.kint.2022.01.035
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1069 / 1072
页数：4
相关论文
共 50 条
  • [1] Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 Infection
    Cappuccilli, Maria
    Semprini, Simona
    Fabbri, Elisabetta
    Fantini, Michela
    Bruno, Paolo Ferdinando
    Spazzoli, Alessandra
    Righini, Matteo
    Flachi, Marta
    La Manna, Gaetano
    Sambri, Vittorio
    Mosconi, Giovanni
    MEDICINA-LITHUANIA, 2022, 58 (07):
  • [2] Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
    Hatakeyama, S.
    Yoneyama, T.
    Hamaya, T.
    Togashi, K.
    Narita, T.
    Fujita, N.
    Yamamoto, H.
    Yoneyama, T.
    Hashimoto, Y.
    Ohyama, C.
    EUROPEAN UROLOGY, 2022, 81 : S47 - S48
  • [3] ANTIBODY RESPONSES TO BNT162B2 MRNA COVID-19 VACCINE IN HEALTHCARE WORKERS AND PATIENTS WITH UROLOGICAL DISEASES IN JAPAN
    Hatakeyama, Shingo
    Yoneyama, Tohru
    Hamaya, Tomoko
    Togashi, Kyo
    Narita, Takuma
    Fujita, Naoki
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2022, 207 (05): : E481 - E481
  • [4] Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
    Racine-Brzostek, Sabrina E.
    Yee, Jim K.
    Sukhu, Ashley
    Qiu, Yuqing
    Rand, Sophie
    Barone, Paul D.
    Hao, Ying
    Yang, He S.
    Meng, Qing H.
    Apple, Fred S.
    Shi, Yuanyuan
    Chadburn, Amy
    Golden, Encouse
    Formenti, Silvia C.
    Cushing, Melissa M.
    Zhao, Zhen
    JCI INSIGHT, 2021, 6 (20)
  • [5] Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
    Liu, Shaojun
    Tsun, Joseph G. S.
    Fung, Genevieve P. G.
    Lui, Grace C. Y.
    Chan, Kathy Y. Y.
    Chan, Paul K. S.
    Chan, Renee W. Y.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies
    Lee, Jenny M.
    Figueroa, Alexis
    Sachithanandham, Jaiprasath
    Li, Maggie
    Connolly, Caoilfhionn M.
    Shapiro, Janna R.
    Chen, Yiqun
    Jones, Michelle
    Dhara, Venkata Gayatri
    Towns, Marilyn
    Lee, John S.
    Peralta, Stephanie R.
    Milstone, Aaron M.
    Betenbaugh, Michael
    Debes, Amanda K.
    Blankson, Joel
    Sitaras, Ioannis
    Yoon, Steve
    Thompson, Elizabeth A.
    Bingham, Clifton O.
    Klein, Sabra L.
    Pekosz, Andrew
    Bailey, Justin R.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] TYPE OF MRNA COVID-19 VACCINE AND TREATMENT INFLUENCE ANTIBODY KINETICS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
    Raptis, C. E.
    Andrey, D. O.
    Polysopoulos, C.
    Berger, C.
    Ciurea, A.
    Lescuyer, P.
    Maletic, T.
    Riek, M.
    Scherer, A.
    von Loga, I.
    Safford, J.
    Lauper, K.
    Moeller, B.
    Vuilleumier, N.
    Finckh, A.
    Rubbert-Roth, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 115 - 116
  • [8] COVID-19 MRNA VACCINE BOOSTER IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES
    Cardelli, C.
    Caruso, T.
    Tani, C.
    Pratesi, F.
    Talarico, R.
    Di Cianni, F.
    Italiano, N.
    Laurino, E.
    Moretti, M.
    Cascarano, G.
    Diomedi, M.
    Gualtieri, L.
    D'urzo, R.
    Migliorini, P.
    Mosca, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1693 - 1693
  • [9] Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease
    Naylor, Kyla L.
    McArthur, Eric
    Dixon, Stephanie N.
    Kwong, Jeffrey C.
    Thomas, Doneal
    Balamchi, Shabnam
    Blake, Peter G.
    Garg, Amit X.
    Atiquzzaman, Mohammad
    Hladunewich, Michelle A.
    Levin, Adeera
    Yeung, Angie
    Oliver, Matthew J.
    KIDNEY INTERNATIONAL, 2023, 103 (04) : 791 - 797
  • [10] COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases
    Cardelli, Chiara
    Caruso, Teresita
    Tani, Chiara
    Pratesi, Federico
    Talarico, Rosaria
    Di Cianni, Federica
    Italiano, Nazzareno
    Laurino, Elenia
    Moretti, Michele
    Cascarano, Giancarlo
    Diomedi, Michele
    Gualtieri, Luca
    D'Urzo, Rossella
    Migliorini, Paola
    Mosca, Marta
    RHEUMATOLOGY, 2022, 61 (11) : E328 - E330
12345